Catherine M. Cahill: Difference between revisions
Content deleted Content added
Reverted 1 edit by 199.111.225.63 (talk): Rv unexplained |
Edited for brevity and facts |
||
| Line 9: | Line 9: | ||
{{AfC submission|t||ts=20240428135744|u=216.197.71.240|ns=118|demo=}}<!-- Important, do not remove this line before article has been created. --> |
{{AfC submission|t||ts=20240428135744|u=216.197.71.240|ns=118|demo=}}<!-- Important, do not remove this line before article has been created. --> |
||
Catherine Cahill |
Catherine Cahill is a professor in the Department of [[Psychiatry]] and Biobehavioral Sciences at the [[University of California, Los Angeles]].<ref name=":2">{{cite web |title=Catherine Cahill, M.Sc., Ph.D. |url=https://bri.ucla.edu/people/catherine-cahill/ |website=UCLA Brain Research Institute |access-date=29 April 2024}}</ref> Her research focuses on how [[chronic pain]] states modulate [[reward circuitry]] and changes [[Dopaminergic pathways|dopaminergic]] transmission responsible for motivated behavior.<ref name=":2" /> |
||
== Early Life and Education == |
== Early Life and Education == |
||
| Line 15: | Line 15: | ||
== Research and Career == |
== Research and Career == |
||
| ⚫ | Dr. Cahill's research investigates how chronic pain can alter specific brain regions associated with emotion, fear, and motivation, and [[neural plasticity]] that occurs due to persistent pain and opioid use.<ref name=":1">{{cite web |last1=Fitzpatrick |first1=Caitlyn |title=5-Year Study Unlocks Link Between Chronic Pain and Depression |url=https://www.hcplive.com/view/5-year-study-unlocks-link-between-chronic-pain-and-depression |website=HCPLive |access-date=29 April 2024}}</ref><ref name=":4">{{cite web |title=Catherine M. Cahill |url=https://research.com/u/catherine-m-cahill |website=Research.com |publisher=Research.com |access-date=29 April 2024}}</ref><ref name=":0" /> Her research is a part of a [[National Institutes of Health]] Funded Center of Excellence on Opioid Research and Drug Addiction [https://www.semel.ucla.edu/hatos/center-study-opioid-receptors-and-drugs-abuse-csorda (CSORDA]).<ref name=":3">{{Cite web |title=Center for Study of Opioid Receptors and Drugs of Abuse (CSORDA) {{!}} Semel Institute for Neuroscience and Human Behavior |url=https://www.semel.ucla.edu/hatos/center-study-opioid-receptors-and-drugs-abuse-csorda |access-date=2024-04-29 |website=www.semel.ucla.edu}}</ref> In addition, her research is supported by the [[National Center for Advancing Translational Sciences]], the [[National Institute on Aging|National Institute of Aging]], the [[National Institute of Dental and Craniofacial Research]], the [[United States Department of Defense|Department of Defense]] and the [https://www.semel.ucla.edu/hatos Shirley and Stefan Hatos Foundation].<ref name=":2" /> |
||
After pursuing her postdoctoral training, Dr. Cahill joined UCLA as a Professor of Psychiatry & Biobehavioral Sciences in 2017 and is a member of the Hatos Center for Neuropharmacology at the University.<ref name=":2" /> |
|||
Dr. Cahill's research focuses on unraveling the neurobiological mechanisms underlying chronic pain while exploring innovative strategies for pain relief.<ref name=":1" /> Her research investigates how chronic pain can alter specific brain regions associated with emotion, fear, and motivation, shedding light on the [[neural plasticity]] that occurs due to persistent pain.<ref name=":1">{{cite web |last1=Fitzpatrick |first1=Caitlyn |title=5-Year Study Unlocks Link Between Chronic Pain and Depression |url=https://www.hcplive.com/view/5-year-study-unlocks-link-between-chronic-pain-and-depression |website=HCPLive |access-date=29 April 2024}}</ref> Cahill's research bridges brain-derived [[neurotrophic factors]] and [[κ-opioid receptor]] investigations within neuroscience, particularly in the realm of receptor function.<ref name=":4">{{cite web |title=Catherine M. Cahill |url=https://research.com/u/catherine-m-cahill |website=Research.com |publisher=Research.com |access-date=29 April 2024}}</ref> |
|||
Cahill’s lab is dedicated to identifying innovative approaches to pain treatment that work to prevent [[opioid]] use disorder.<ref name=":0" /> The lab is currently focused on identifying κ-opioid receptors as a therapeutic objective for addressing chronic pain, identifying the roles of receptors of [[Neuron|neurons]] in the [[striatum]], examining the contribution of microglial activation and understanding the emotional aspect of pain via the kappa opioid system.<ref name=":4" /> |
|||
| ⚫ | Her research is a part of a [[National Institutes of Health]] Funded Center of Excellence on Opioid Research and Drug Addiction [https://www.semel.ucla.edu/hatos/center-study-opioid-receptors-and-drugs-abuse-csorda (CSORDA]).<ref name=":3">{{Cite web |title=Center for Study of Opioid Receptors and Drugs of Abuse (CSORDA) {{!}} Semel Institute for Neuroscience and Human Behavior |url=https://www.semel.ucla.edu/hatos/center-study-opioid-receptors-and-drugs-abuse-csorda |access-date=2024-04-29 |website=www.semel.ucla.edu}}</ref> In addition, her research is supported by the [[National Center for Advancing Translational Sciences]], the [[National Institute on Aging|National Institute of Aging]], the [[National Institute of Dental and Craniofacial Research]], the [[United States Department of Defense|Department of Defense]] and the [https://www.semel.ucla.edu/hatos Shirley and Stefan Hatos Foundation].<ref name=":2" /> |
||
== Honors and Awards == |
== Honors and Awards == |
||
Cahill has |
Cahill has rthe Research Excellence Award (2003) and the [https://www.emdgroup.com/en/company/merck-young-scientist-awards.html Merck Junior Scientist Award] from the Canadian Pharmacology and Therapeutics Society (2008).<ref name=":0">{{cite web |title=Catherine Cahill |url=https://loop.frontiersin.org/people/155829/bio |publisher=Loop |access-date=29 April 2024}}</ref> Along with these, she received the [https://www.iasp-pain.org/resources/grants-awards/ronald-melzack-lecture-award/ Ronald Melzack Pain Research Award] (1998), [https://www.anatomy.org/AAA/AAA/Awards/Basmajian-Award.aspx Basmajian Award for Excellence in Biomedical Research Award] (2003), the Environment of Inquiry Award from [[University of California, Irvine|University of California Irvine]] (2014), and Junior Scientist Award from [[Canadian Society of Pharmacology and Therapeutics]] (2009)<ref name=":0" />. |
||
== References ==<!-- Inline citations added to your article will automatically display here. See en.wikipedia.org/wiki/WP:REFB for instructions on how to add citations. --> |
== References ==<!-- Inline citations added to your article will automatically display here. See en.wikipedia.org/wiki/WP:REFB for instructions on how to add citations. --> |
||
Revision as of 15:16, 29 April 2024
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
 | This article, Catherine M. Cahill, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author |
Catherine Cahill is a professor in the Department of Psychiatry and Biobehavioral Sciences at the University of California, Los Angeles.[1] Her research focuses on how chronic pain states modulate reward circuitry and changes dopaminergic transmission responsible for motivated behavior.[1]
Early Life and Education
Catherine Cahill received a Bachelor of Science in Chemistry from Mount Allison University (1987) and subsequently completed her Masters of Science and PhD in the Department of Pharmacology from Dalhousie University (1996) under Dr. Jana Sawynok.[2] She would go on to pursue postdoctoral training at the Clinical Research Institute of Montreal (1996-1998) under Dr. Andy Dray and Dr. Terence Coferre, the Montreal Neurological Institute (1998-2002) under Dr. Alain Beaudet, and McGill University with Dr. James Henry.[3]
Research and Career
Dr. Cahill's research investigates how chronic pain can alter specific brain regions associated with emotion, fear, and motivation, and neural plasticity that occurs due to persistent pain and opioid use.[4][5][6] Her research is a part of a National Institutes of Health Funded Center of Excellence on Opioid Research and Drug Addiction (CSORDA).[7] In addition, her research is supported by the National Center for Advancing Translational Sciences, the National Institute of Aging, the National Institute of Dental and Craniofacial Research, the Department of Defense and the Shirley and Stefan Hatos Foundation.[1]
Honors and Awards
Cahill has rthe Research Excellence Award (2003) and the Merck Junior Scientist Award from the Canadian Pharmacology and Therapeutics Society (2008).[6] Along with these, she received the Ronald Melzack Pain Research Award (1998), Basmajian Award for Excellence in Biomedical Research Award (2003), the Environment of Inquiry Award from University of California Irvine (2014), and Junior Scientist Award from Canadian Society of Pharmacology and Therapeutics (2009)[6].
References
- ^ a b c "Catherine Cahill, M.Sc., Ph.D." UCLA Brain Research Institute. Retrieved 29 April 2024.
- ^ "Catherine Marie Cahill". Graduate Programs in Bioscience. UCLA. Retrieved 29 April 2024.
- ^ "Catherine Cahill". LinkedIn.
- ^ Fitzpatrick, Caitlyn. "5-Year Study Unlocks Link Between Chronic Pain and Depression". HCPLive. Retrieved 29 April 2024.
- ^ "Catherine M. Cahill". Research.com. Research.com. Retrieved 29 April 2024.
- ^ a b c "Catherine Cahill". Loop. Retrieved 29 April 2024.
- ^ "Center for Study of Opioid Receptors and Drugs of Abuse (CSORDA) | Semel Institute for Neuroscience and Human Behavior". www.semel.ucla.edu. Retrieved 2024-04-29.